MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
May 6 04:30 ET
MABPHARM-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 21, 2024
Apr 18 04:39 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 04:30 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 02:23 ET
MABPHARM-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 23 03:36 ET
MABPHARM-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 23 03:32 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 5 04:22 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 3 02:46 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 4, 2023 00:51 ET
MABPHARM-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Nov 28, 2023 05:34 ET
MABPHARM-B: (1) RESIGNATION OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR (2) APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR
Nov 28, 2023 05:28 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Nov 2, 2023 23:11 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Oct 4, 2023 02:33 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Sep 3, 2023 22:27 ET
MABPHARM-B: VOLUNTARY ANNOUNCEMENT BUSINESS COOPERATION AGREEMENT WITH JIANGSU SIMCERE ZAIMING IN RELATION TO CMAB009 IN CHINA
Aug 20, 2023 06:06 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Aug 2, 2023 02:05 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Jul 4, 2023 02:36 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Jun 6, 2023 04:38 ET
MABPHARM-B: INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT, CMAB007 (OMALIZUMAB ALFA FOR INJECTION)
May 23, 2023 10:50 ET
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
May 4, 2023 22:05 ET
No Data
No Data